Export

EN
FR
Isoniazid + pyrazinamide + rifampicin
Essential medicine status
General description
Isoniazid + pyrazinamid + rifampicin is a medication used to treat tuberculosis.
INN
Isoniazid + pyrazinamide + rifampicin
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1997 (TRS 882) for Tuberculosis
Therapeutic equivalent for
Recommendations
Section
Antituberculosis medicines
  • Oral > Solid: 50 mg + 150 mg + 75 mg tablet (dispersible); 75 mg + 400 mg + 150 mg tablet
Indications